ImmunoGen, Inc.
Hedge Funds Holdings
Last updated:
ImmunoGen, Inc.‘s stocks are currently a part of 201 hedge funds’ portfolios, which represents 93.35% of the total amount of its stocks outstanding. This makes up a total of 192.42M shares of ImmunoGen, Inc.. Compared to the previous quarter, the number grew by 1.38% or 2.62M shares more. As for the holding position changes, 36.82% (74) of current hedge fund investors increased the number of shares held, 30.35% (61) of current holders sold a part of the shares held, and 20.4% (41) closed the holdings completely. 27 hedge funds are new holders of ImmunoGen, Inc. stock in Q1 2022, it is 13.43% of total holders.
Hedge funds holding ImmunoGen (Q2 2017 – Q1 2022)
| Q2 2017 | 153 |
|---|---|
| Q3 2017 | 175 |
| Q4 2017 | 191 |
| Q1 2018 | 200 |
| Q2 2018 | 191 |
| Q3 2018 | 198 |
| Q4 2018 | 187 |
| Q1 2019 | 195 |
| Q2 2019 | 175 |
| Q3 2019 | 173 |
| Q4 2019 | 182 |
| Q1 2020 | 174 |
| Q2 2020 | 181 |
| Q3 2020 | 170 |
| Q4 2020 | 203 |
| Q1 2021 | 208 |
| Q2 2021 | 204 |
| Q3 2021 | 207 |
| Q4 2021 | 222 |
| Q1 2022 | 201 |
Hedge funds changes in ImmunoGen positions (Q2 2017 – Q1 2022)
| Q2 2017 | 36 | 41 | 45 | 6 | 25 |
|---|---|---|---|---|---|
| Q3 2017 | 39 | 43 | 56 | 16 | 21 |
| Q4 2017 | 47 | 62 | 50 | 29 | 3 |
| Q1 2018 | 45 | 57 | 68 | 34 | -4 |
| Q2 2018 | 27 | 73 | 52 | 34 | 5 |
| Q3 2018 | 35 | 60 | 61 | 29 | 13 |
| Q4 2018 | 34 | 66 | 56 | 45 | -14 |
| Q1 2019 | 37 | 64 | 54 | 29 | 11 |
| Q2 2019 | 25 | 59 | 51 | 40 | 0 |
| Q3 2019 | 27 | 52 | 59 | 30 | 5 |
| Q4 2019 | 35 | 57 | 56 | 25 | 9 |
| Q1 2020 | 30 | 70 | 45 | 34 | -5 |
| Q2 2020 | 30 | 66 | 50 | 24 | 11 |
| Q3 2020 | 16 | 48 | 68 | 28 | 10 |
| Q4 2020 | 44 | 55 | 71 | 12 | 21 |
| Q1 2021 | 32 | 71 | 71 | 26 | 8 |
| Q2 2021 | 31 | 67 | 58 | 34 | 14 |
| Q3 2021 | 28 | 59 | 76 | 23 | 21 |
| Q4 2021 | 42 | 89 | 53 | 27 | 11 |
| Q1 2022 | 27 | 74 | 61 | 41 | -2 |
Hedge funds changes in ImmunoGen stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 4,327,000 | 1,700,000 |
|---|---|---|
| Q3 2017 | 5,987,000 | 5,375,000 |
| Q4 2017 | 3,448,000 | 1,944,000 |
| Q1 2018 | 8,846,000 | 27,496,000 |
| Q2 2018 | 8,067,000 | 8,013,000 |
| Q3 2018 | 16,855,000 | 2,218,000 |
| Q4 2018 | 18,370,000 | 3,492,000 |
| Q1 2019 | 13,064,000 | 10,343,000 |
| Q2 2019 | 2,472,000 | 860,000 |
| Q3 2019 | 2,463,000 | 476,000 |
| Q4 2019 | 2,700,000 | 777,000 |
| Q1 2020 | 1,012,000 | 566,000 |
| Q2 2020 | 891,000 | 803,000 |
| Q3 2020 | 945,000 | 559,000 |
| Q4 2020 | 3,911,000 | 4,088,000 |
| Q1 2021 | 7,099,000 | 3,560,000 |
| Q2 2021 | 12,855,000 | 1,072,000 |
| Q3 2021 | 17,004,000 | 6,540,000 |
| Q4 2021 | 11,795,000 | 6,802,000 |
| Q1 2022 | 6,121,000 | 1,697,000 |